Acute motor axonal neuropathy (AMAN) is a rare type of Guillain-Barré syndrome (GBS) that is characterized by the sudden onset of muscle weakness and paralysis. It is caused by damage to the axons of the peripheral nerves, which are responsible f...

Acute myeloblastic leukemia with maturation (AML-M) is a type of acute myeloid leukemia (AML) in which there is a maturation of the myeloid cells. It is characterized by the presence of immature myeloid cells in the bone marrow, along with more ma...

Acute myeloblastic leukemia without maturation (AML-M0) is a type of acute myeloid leukemia (AML) in which the bone marrow contains immature myeloblasts (immature white blood cells) that lack the features of normal mature cells. It is a rare form ...

Acute myeloid leukaemia with myelodysplasia-related features (AML-MDS) is a type of acute myeloid leukaemia (AML) that is associated with features of myelodysplastic syndrome (MDS). It is a rare form of AML that is characterized by the presence of...

Acute myeloid leukemia (AML) is a type of cancer that affects the blood and bone marrow. It is a rapidly progressing disease in which the body produces abnormal white blood cells that interfere with the production of normal blood cells. Symptoms o...

Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are both types of blood cancers that can be caused by exposure to alkylating agents. Alkylating agents are a type of chemotherapy drug that works by damaging the DNA of cancer cells,...

Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are both types of blood cancers that can be caused by exposure to radiation. Radiation can damage the DNA of cells, leading to mutations that can cause cancer. People who have been e...

Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are both types of blood cancers that are related to topoisomerase type 2 inhibitor drugs. Topoisomerase type 2 inhibitors are drugs that target an enzyme called topoisomerase II, whi...

Acute myeloid leukemia with 11q23 abnormalities is a type of acute myeloid leukemia (AML) that is characterized by a chromosomal abnormality involving the 11q23 region of the genome. This abnormality is associated with a poor prognosis and is ofte...

Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) is a type of acute myeloid leukemia (AML) characterized by an abnormal chromosomal translocation involving the 16th chromosome. This translocation re...

Acute myeloid leukemia with CEBPA somatic mutations is a type of acute myeloid leukemia (AML) that is characterized by the presence of somatic mutations in the CEBPA gene. These mutations are acquired during a person's lifetime and are not inherit...

Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) is a rare subtype of acute myeloid leukemia (AML) characterized by a chromosomal abnormality involving the long arm of chromosome 3. This abnormality is caused by a translocation, i...

Acute myeloid leukemia with minimal differentiation (AML-MD) is a type of acute myeloid leukemia (AML) that is characterized by a lack of differentiation of the cancerous cells. This means that the cells have not developed into the mature cells th...

Acute myeloid leukemia with NPM1 somatic mutations is a type of acute myeloid leukemia (AML) that is characterized by the presence of somatic mutations in the NPM1 gene. These mutations are associated with a poorer prognosis and a higher risk of r...

Acute myeloid leukemia with t(6;9)(p23;q34) is a rare subtype of acute myeloid leukemia (AML) characterized by a chromosomal translocation between chromosomes 6 and 9. This translocation results in the fusion of two genes, ETV6 and RUNX1, which le...

Acute myeloid leukemia with t(8;16)(p11;p13) translocation is a rare subtype of acute myeloid leukemia (AML) characterized by a chromosomal translocation between chromosomes 8 and 16. This translocation results in the fusion of the genes RUNX1 and...

Acute myeloid leukemia with t(8;21)(q22;q22) translocation is a type of acute myeloid leukemia (AML) characterized by a specific chromosomal translocation between chromosomes 8 and 21. This translocation results in the fusion of two genes, RUNX1 a...